Vacinox Is a Biotechnology Firm That Is About to Announce

Multiple Choice

Vacinox is a biotechnology firm that is about to announce the results of its clinical trials of a potential new vaccine.If the trials are successful,Vacinox stock will be worth $80 per share.However,if the trials are not successful,then Vacinox stock will only be worth $12 per share.If on the morning that the announcement is scheduled,Vacinox stock is trading for $60.96,then the probability that investors place on the trials being successful are closest to:

A) 48%.
B) 50%.
C) 60%.
D) 72%.